Withings always has something exciting to show at CES, and this year, the health tech company highlighted the latest version of its smart scale, rather smart station, the Body Scan 2.
The upgraded device introduces more than 60 biomarkers, including a hypertension risk notification, full assessment of cardiac pumping efficiency via Impedance Cardiography (ICG), an in-depth evaluation of cellular health, metabolic efficiency, and glycemic regulation enabled by ultra-high frequency bioimpedance spectroscopy (BIS), and more. The idea is to not just provide your weight, body mass index, body fat percentage, but also actionable and preventative insights.
“The most powerful place to reinvent preventive health is the connected scale,” says Eric Carreel, Founder & President of Withings. “It’s the only moment where we naturally engage our whole body — hands, feet, posture — allowing us to capture more biomarkers in 90 seconds than any wearable can collect in weeks. Body Scan 2 turns this everyday gesture into a deep health assessment.”
Body Scan 2’s 60 biomarkers were selected for their predictive value on long-term health. Body Scan 2 delivers a 90-second multimodal longevity assessment analyzing the core physiological systems that drive long-term health: Heart Pumping Performance & Heart Electrical Activity Embedded Technology with, for the first time on a scale, Impedance Cardiography (ICG). This is combined with a 6-lead ECG that measures the heart’s capacity to powerfully pump blood to the organs. Biomarkers include cardiac efficiency, cardiac reactivity, heart age (ICG), cardiac rhythm & electrical activity (ECG), and Atrial Fibrillation Detection. Under-performance in heart-pumping function can cause fatigue, impaired stress resilience, and low endurance, says Withings. Detecting it early allows for lifestyle adjustments, like addressing a sedentary lifestyle or chronic stress, to maintain daily energy, preserve long-term heart health, and ensure overall longevity.
Hypertension Risk Notification Embedded Technology is clinically validated and provides arterial hypertension risk indications without the need for a cuff. This can help you address the leading risk factor for stroke, which affects nearly half of American adults and often goes underdiagnosed. There’s also Artery Health that captures arterial elasticity and vascular age through Pulse Wave Velocity (PWV) that measures the stiffness of arteries in the arms and legs. The biomarkers include arterial elasticity, vascular age, and early arterial stiffness detection, a key early predictor of future cardiovascular health that remains highly actionable.
Also captured is Cellular Health & Metabolic Efficiency through ultra-high-frequency Bioimpedance Spectroscopy (BIS). This tells you cellular age, active cell mass (ACM), and metabolic efficiency, allowing for early detection of metabolic slowdown or inflammation. Glycemic Regulation, also clinically validated, detects early signs of potential glycemic dysregulation, which is one of the first things to shift silently due to poor lifestyle habits. Detecting it early, says Withings, can help prevent abdominal fat gain, chronic fatigue, and the progression toward prediabetes.
Body Scan 2 establishes each user’s individual physiological baselines, detects early deviations while they are still reversible, and delivers personalized recommendations that strengthen metabolic, cardiovascular, and cellular resilience. It provides a Health Trajectory score, which offers a clear view of long-term health, motivating users by showing how lifestyle changes could extend their health span. Body Scan 2 guidance is especially valuable during periods that challenge cardiometabolic balance, like chronic stress, sedentary routines, midlife visceral and abdominal fat gain, perimenopause and menopause, athletic training, or GLP-1 weight-loss treatments where muscle preservation is essential.
The scale has a tempered-glass surface that houses eight ITO-embedded electrodes, combined with four stainless steel electrodes in the handle, to measure over 60 biomarkers. The retractable handle features a bright, high-resolution LCD for viewing results during weigh-ins, and two buttons for answering personalized lifestyle questions and receiving longevity coaching prompts. The rechargeable battery lasts up to 15 months, and all health data syncs automatically to the Withings app via Wi-Fi or Bluetooth.
The Withings Body Scan 2 is pending FDA clearance for select metrics in the U.S., but is scheduled to be released in Q2 2026 for US$600; there’s no word yet on Canadian availability, pricing, or Health Canada approval.